Treating hyperglycemia in type 2 diabetes: New goals and strategies
A practical perspective on how to use the new oral drugs and insulins, alone and in combination.
HAROLD E. LEBOVITZ, MD
Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes, State University of New York (SUNY) Health Sciences Center, Brooklyn
ADDRESS: Harold E. Lebovitz, MD, 416 Henderson Avenue, Staten Island, NY 10310.
To achieve glycemic goals in type 2 diabetes, one must usually use combinations of oral agents or oral agents plus insulin. This paper discusses the metabolic derangements of type 2 diabetes, the different classes of antihyperglycemic drugs, and strategies for using these drugs rationally.